[Federal Register Volume 76, Number 82 (Thursday, April 28, 2011)]
[Notices]
[Pages 23826-23827]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-10296]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant applications, the disclosure of which
[[Page 23827]]
would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA B/START Small Grant Review.
Date: May 11, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd,.
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, New Molecular Entities to Treat Substance Use
Disorders.
Date: May 24, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Sofitel Washington DC Lafayette Square, 806 15th Street,
NW., Washington, DC 20005.
Contact Person: Jose F. Ruiz, PhD, Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse, NIH,
Room 4228, MSC 9550, 6001 Executive Blvd, Bethesda, MD 20892-9550,
301-451-3086, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA I/START Small Grant Review.
Date: May 25, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA I/START Small Grant Review.
Date: May 25, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA I/START Small Grant Review.
Date: May 25, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, NIDA B/START Small Grant Review.
Date: June 8, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Gerald L. McLaughlin, PhD, Scientific Review
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4238, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-402-6626, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Training and Career Development Subcommittee.
Date: June 29-30, 2011.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes
Street, Arlington, VA 22202.
Contact Person: Eliane Lazar-Wesley, PhD, Health Scientist
Administrator, Office of Extramural Affairs, National Institute on
Drug Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd.,
Bethesda, MD 20892-9550, 301-451-4530, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: April 21, 2011.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-10296 Filed 4-27-11; 8:45 am]
BILLING CODE 4140-01-P